Jazz Seen Next Target Amid Ireland’s Drug Deal Frenzy

Jazz Seen Next Target Amid Ireland’s Drug Deal Frenzy

Barry Cronin/Bloomberg

Both Jazz, which is now valued at $4.5 billion, and Alkermes, with a market capitalization of $4.6 billion, rallied after Elan’s takeover was announced on July 29.